Anni Christensen

1.3k total citations
35 papers, 1.1k citations indexed

About

Anni Christensen is a scholar working on Cancer Research, Molecular Biology and Hematology. According to data from OpenAlex, Anni Christensen has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cancer Research, 20 papers in Molecular Biology and 18 papers in Hematology. Recurrent topics in Anni Christensen's work include Protease and Inhibitor Mechanisms (24 papers), Blood Coagulation and Thrombosis Mechanisms (17 papers) and Biochemical and Structural Characterization (6 papers). Anni Christensen is often cited by papers focused on Protease and Inhibitor Mechanisms (24 papers), Blood Coagulation and Thrombosis Mechanisms (17 papers) and Biochemical and Structural Characterization (6 papers). Anni Christensen collaborates with scholars based in Denmark, United States and China. Anni Christensen's co-authors include Peter A. Andreasen, Roger A. Garrett, Jan K. Jensen, Stephen Douthwaite, Katrine E. Pedersen, Christian W. Heegaard, Troels Wind, Lawrence Chan, Kazuhiro Oka and Helle H. Petersen and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Anni Christensen

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anni Christensen Denmark 21 622 583 315 156 148 35 1.1k
Troels Wind Denmark 18 412 0.7× 474 0.8× 328 1.0× 91 0.6× 120 0.8× 28 873
Jieyi Wang United States 15 443 0.7× 342 0.6× 127 0.4× 78 0.5× 291 2.0× 29 851
Mary Jo Murnane United States 19 637 1.0× 378 0.6× 102 0.3× 106 0.7× 242 1.6× 32 1.2k
Laura A. Rudolph‐Owen United States 10 763 1.2× 336 0.6× 94 0.3× 134 0.9× 361 2.4× 12 1.2k
Rhonda M. Lachance United States 16 508 0.8× 263 0.5× 196 0.6× 514 3.3× 112 0.8× 17 1.2k
Sadako Yamagata Japan 19 580 0.9× 359 0.6× 78 0.2× 145 0.9× 275 1.9× 47 1.1k
Daniel Keppler United States 16 482 0.8× 461 0.8× 49 0.2× 100 0.6× 206 1.4× 21 959
Neelam Shirsat India 22 692 1.1× 331 0.6× 113 0.4× 36 0.2× 193 1.3× 53 1.1k
Gaynor Davies United Kingdom 19 576 0.9× 255 0.4× 47 0.1× 141 0.9× 351 2.4× 22 1.0k

Countries citing papers authored by Anni Christensen

Since Specialization
Citations

This map shows the geographic impact of Anni Christensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anni Christensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anni Christensen more than expected).

Fields of papers citing papers by Anni Christensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anni Christensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anni Christensen. The network helps show where Anni Christensen may publish in the future.

Co-authorship network of co-authors of Anni Christensen

This figure shows the co-authorship network connecting the top 25 collaborators of Anni Christensen. A scholar is included among the top collaborators of Anni Christensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anni Christensen. Anni Christensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kidmose, R.T., et al.. (2025). Integrative in silico and biochemical analyses demonstrate direct Arl3-mediated ODA16 release from the intraflagellar transport machinery. Journal of Biological Chemistry. 301(3). 108237–108237. 2 indexed citations
2.
Harazin, András, et al.. (2023). Analysis of cortical cell polarity by imaging flow cytometry. Journal of Cellular Biochemistry. 124(11). 1685–1694. 1 indexed citations
3.
Jiang, Longguang, Baoyu Zhao, Peng Xu, et al.. (2015). Distinctive binding modes and inhibitory mechanisms of two peptidic inhibitors of urokinase-type plasminogen activator with isomeric P1 residues. The International Journal of Biochemistry & Cell Biology. 62. 88–92. 2 indexed citations
4.
Zhao, Baoyu, Peng Xu, Longguang Jiang, et al.. (2014). A Cyclic Peptidic Serine Protease Inhibitor: Increasing Affinity by Increasing Peptide Flexibility. PLoS ONE. 9(12). e115872–e115872. 20 indexed citations
5.
Jiang, Longguang, Jan K. Jensen, Anni Christensen, et al.. (2013). Bicyclic Peptide Inhibitor of Urokinase‐Type Plasminogen Activator: Mode of Action. ChemBioChem. 14(16). 2179–2188. 16 indexed citations
6.
Kristensen, Thomas K., Jan K. Jensen, Anni Christensen, et al.. (2012). Urokinase-type Plasminogen Activator-like Proteases in Teleosts Lack Genuine Receptor-binding Epidermal Growth Factor-like Domains. Journal of Biological Chemistry. 287(33). 27526–27536. 9 indexed citations
7.
Sølling, Christoffer, Anni Christensen, Uffe Nygaard, et al.. (2011). Erythropoietin does not attenuate renal dysfunction or inflammation in a porcine model of endotoxemia. Acta Anaesthesiologica Scandinavica. 55(4). 411–421. 20 indexed citations
8.
Jiang, Longguang, Hans Peter Sørensen, Jan K. Jensen, et al.. (2011). The Binding Mechanism of a Peptidic Cyclic Serine Protease Inhibitor. Journal of Molecular Biology. 412(2). 235–250. 15 indexed citations
9.
Hosseini, Masood, Longguang Jiang, Hans Peter Sørensen, et al.. (2011). Elucidation of the Contribution of Active Site and Exosite Interactions to Affinity and Specificity of Peptidylic Serine Protease Inhibitors Using Non-Natural Arginine Analogs. Molecular Pharmacology. 80(4). 585–597. 22 indexed citations
10.
Mathiasen, Lisa, Daniel M. Dupont, Anni Christensen, et al.. (2008). A Peptide Accelerating the Conversion of Plasminogen Activator Inhibitor-1 to an Inactive Latent State. Molecular Pharmacology. 74(3). 641–653. 22 indexed citations
11.
Dupont, Daniel M., Grant E. Blouse, Lisa Mathiasen, et al.. (2006). Evidence for a Pre-latent Form of the Serpin Plasminogen Activator Inhibitor-1 with a Detached β-Strand 1C. Journal of Biological Chemistry. 281(47). 36071–36081. 34 indexed citations
12.
Hansen, Martin, Troels Wind, Grant E. Blouse, et al.. (2005). A Urokinase-type Plasminogen Activator-inhibiting Cyclic Peptide with an Unusual P2 Residue and an Extended Protease Binding Surface Demonstrates New Modalities for Enzyme Inhibition. Journal of Biological Chemistry. 280(46). 38424–38437. 48 indexed citations
13.
Durand, Michelle, Julie Støve Bødker, Anni Christensen, et al.. (2004). Plasminogen activator inhibitor-1 and tumour growth, invasion, and metastasis. Thrombosis and Haemostasis. 91(3). 438–449. 129 indexed citations
14.
Aaboe, Mads, Birgitte Vrou Offersen, Anni Christensen, & Peter A. Andreasen. (2003). Vitronectin in human breast carcinomas. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1638(1). 72–82. 41 indexed citations
15.
Egelund, Rikke, Anja P. Einholm, Katrine E. Pedersen, et al.. (2001). A Regulatory Hydrophobic Area in the Flexible Joint Region of Plasminogen Activator Inhibitor-1, Defined with Fluorescent Activity-neutralizing Ligands. Journal of Biological Chemistry. 276(16). 13077–13086. 58 indexed citations
16.
Oka, Kazuhiro, Lars Ellgaard, Helle H. Petersen, et al.. (1999). Ligand Binding Properties of the Very Low Density Lipoprotein Receptor. Journal of Biological Chemistry. 274(13). 8973–8980. 26 indexed citations
17.
18.
Kasza, Aneta, Helle H. Petersen, Christian W. Heegaard, et al.. (1997). Specificity of Serine Proteinase/Serpin Complex Binding to Very‐Low‐Density Lipoprotein Receptor and α2‐Macroglobulin Receptor/Low‐Density‐Lipoprotein‐Receptor‐Related Protein. European Journal of Biochemistry. 248(2). 270–281. 79 indexed citations
19.
Heegaard, Christian W., Kazuhiro Oka, Anni Christensen, et al.. (1995). Very Low Density Lipoprotein Receptor Binds and Mediates Endocytosis of Urokinase-type Plasminogen Activator-Type-1 Plasminogen Activator Inhibitor Complex. Journal of Biological Chemistry. 270(35). 20855–20861. 101 indexed citations
20.
Egebjerg, Jan, Henrik Leffers, Anni Christensen, Henrik Andersen, & Roger A. Garrett. (1987). Structure and accessibility of domain I of Escherichia coli 23 S RNA in free RNA, in the L24-RNA complex and in 50 S subunits. Journal of Molecular Biology. 196(1). 125–136. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Troels Wind Breakdown of academic impact, for papers by Jieyi Wang Breakdown of academic impact, for papers by Mary Jo Murnane Breakdown of academic impact, for papers by Laura A. Rudolph‐Owen Breakdown of academic impact, for papers by Rhonda M. Lachance Breakdown of academic impact, for papers by Sadako Yamagata Breakdown of academic impact, for papers by Daniel Keppler Breakdown of academic impact, for papers by Neelam Shirsat Breakdown of academic impact, for papers by Gaynor Davies
Rankless by CCL
2026